November 2, 1999 |
Lake Forest-based I-Flow Corp. said it has received permission from the Food and Drug Administration to market a new catheter to help manage pain in large surgical incisions. The company, which makes ambulatory infusion systems, said the new soaker catheter delivers local anesthesia directly across long incisions for such surgeries as hysterectomies, C-sections and open-heart procedures. I-Flow's shares closed Monday at $4.25, up 3 cents, on the Nasdaq Small Capitalization
December 8, 1995
I-Flow Corp. is planning its first entry into the Brazilian market. The company, which develops and markets ambulatory infusion systems, said Thursday it has signed a five-year distribution agreement with one of Brazil's largest pharmaceutical companies, Laboratorio Biosintetica Ltd. of Sao Paulo. Laboratorio Biosintetica will distribute I-Flow's Paragon and Band-It syringe delivery products under terms of the agreement. The company generates revenue of more than $70 million in revenue a year.
June 3, 1998 |
I-Flow Corp. said Tuesday it received approval from the U.S. Food and Drug Administration to market its disposable PainBuster infusion pain management kit for orthopedic surgery patients. I-Flow said the system uses Bupivacaine HC1, a nonnarcotic drug, avoiding the side effects of narcotics like morphine. The drug is infused directly into a patient 24 to 48 hours after an operation, The Lake Forest company's stock climbed 13%, or 25 cents, to $2.13 a share.
November 8, 1992
I-Flow Corp., a manufacturer of medical devices, reported a third-quarter loss of $812,000, or 14 cents a share, compared with a loss of $812,000, or 26 cents a share, for the same period a year earlier. Revenue rose to $615,000 from $114,000. For the first three quarters of 1992, the company lost $2.8 million, or 59 cents a share, on revenue of $1.1 million. That compared with a loss of $2.5 million, or 96 cents a share, on revenue of $261,000 for the corresponding 1991 period.
December 24, 1993
I-Flow Corp. said this week it received $4.5 million from an offering of common stock and warrants. I-Flow sold 772,000 units--one warrant and one share each--in a private placement in the United States and 1.5 million units in Europe. The warrant entitles a holder to purchase another share at $3 before December, 1996. The stock closed Monday at $2.0625 on the Nasdaq, down 6.25 cents. I-Flow makes devices for infusing several fluids at once intravenously into patients.
December 27, 2000 |
Lake Forest infusion products maker I-Flow Corp. said Tuesday that a federal agency has rescinded its approval for Medicare payments for the company's outpatient pain-management surgical procedures. I-Flow said in a press release that the Health Care Financing Administration decided to deny payments for its proprietary ON-Q and PainBuster pain-management systems because of "budgetary restrictions" on the agency.
October 20, 2000 |
I-Flow Corp., a Lake Forest developer of low-cost ambulatory infusion systems, said Thursday that it has signed a contingent agreement to settle its lawsuit against a small Minnesota company. I-Flow and Novacon Corp. in Lake Elmo, Minn., said in separate press releases that the settlement will take the place of a $1.3-million judgment awarded to I-Flow in its patent infringement case over a Novacon drug infusion balloon.
August 2, 1996
I-Flow Corp., which posted a profitable quarter and first six months, said Thursday that it expects a third-quarter loss because of a write-off and expenses totaling $5.6 million. The developer of ambulatory infusion systems said that it will write off $5 million for research and development costs and will incur $600,000 in additional expenses related to its acquisition last month of Block Medical operations.